|
EX1
|
Biostatistics, public health
|
A
|
Suggests only include cancers diagnosed from period of intervention.
|
|
EX2
|
Biostatistics, clinical trials and cancer research
|
A
| |
|
EX3
|
Statistics
|
A
|
Ticked “alternative” but suggested hybrid of A for testing and C for estimation—interpreted as A
|
|
EX4
|
Cancer epidemiology, prevention and screening
|
Change analysis
|
Suggested “number needed to screen”.
|
|
EX5
|
Biostatistics, cancer epidemiology
|
Change analysis
|
Did not complete form but indicated choice by email, test based on difference of restricted mean survival time (RMST).
|
|
EX6
|
Biostatistics and epidemiology
|
Change analysis
|
Suggested splitting data into yearly bins and assess HR in each, possibly with smoothing. Avoid single HR.
|
|
EX7
|
Biostatistics, clinical trials and cancer research
|
C
|
Did not complete form but indicated choice by email. Prefers more parsimonious model with interpretable parameters.
|
|
EX8
|
Biostatistics, clinical trials
|
C
| |
|
EX9
|
Biostatistics, public health
|
C
|
Prefers more parsimonious model with interpretable parameters.
|
|
EX10
|
Cancer epidemiology, public health
|
C
|
Also suggests “versatile weighted log-rank test”
|
|
EX11
|
Statistics, public policy
|
C
| |
|
EX12
|
Biostatistics
|
–
|
Did not respond within timeframe
|
